According to the American Society of Clinical Oncology guideline and the latest St Gallen consensus, TNBC is defined as a breast tumor without expression of estrogen (ER), progesterone receptor (PR), and neither expression nor amplification of HER2/neu.8 This evidence concerns the gene ERBB2 and breast neoplasm.